Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

Immunity

Volumn 9, Issue 3, 1998, Pages 405-411

  Caldwell, Robert G ^a   Wilson, Joanna B ^b   Anderson, Steven J ^a   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; DNA; IMMUNOGLOBULIN HEAVY CHAIN; INTERLEUKIN 7; LATENT MEMBRANE PROTEIN 2A; LEUKOSIALIN; LYMPHOCYTE RECEPTOR; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL MATURATION; CELL SURVIVAL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; LATENT VIRUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN CELL; TRANSGENIC MOUSE;

EID: 0032169313     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80623-8     Document Type: Article

References (45)

1. Babcock, G.J., Decker, L.L., Volk, M., and Thorley-Lawson, D.A. (1998). EBV persistence in memory B cells in vivo. Immunity 9, 395-404.
2. Braeuninger, A., Kuppers, R., Strickler, J.G., Wacker, H.H., Rajewsky, K., and Hansmann, M.L. (1997). Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells. Proc. Natl. Acad. Sci. USA 94, 9337-9342.
3. Burkhardt, A.L., Bolen, J.B., Kieff, E., and Longnecker, R. (1992). An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J. Virol. 66, 5161-5167.
4. Chen, F., Zou, J.Z., di Renzo, L., Winberg, G., Hu, L.F., Klein, E., Klein, G., and Ernberg, I. (1995). A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69, 3752-3758.
5. Cheng, A.M., Rowley, B., Pao, W., Hayday, A., Bolen, J.B., and Pawson, T. (1995). Syk tyrosine kinase required for mouse viability and B-cell development. Nature 378, 303-306.
6. Dush, M.K., Sikela, J.M., Khan, S.A., Tischfield, J.A., and Stambrook, P.J. (1985). Nucleotide sequence and organization of the mouse adenine phosphoribosyltransferase gene: presence of a coding region common to animal and bacterial phosphoribosyltransferases that has a variable intron/exon arrangement. Proc. Natl. Acad. Sci. USA 82, 2731-2735.
7. Era, T., Ogawa, M., Nishikawa, S., Okamoto, M., Honjo, T., Akagi, K., Miyazaki, J., and Yamamura, K. (1991). Differentiation of growth signal requirement of B lymphocyte precursor is directed by expression of immunoglobulin. EMBO J. 10, 337-342.
8. Fruehling, S., Lee, S., Herrold, R., Frech, B., Laux, G., Kremmer, E., Grässer, F.A., and Longnecker, R. (1996). Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J. Virol. 70, 6216-6226.
9. Fruehling, S., and Longnecker, R. (1997). The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235, 241-251.
10. Gratama, J.W., Oosterveer, M.A., Zwaan, F.E., Lepoutre, J., Klein, G., and Ernberg, I. (1988). Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency. Proc. Natl. Acad. Sci. USA 85, 8693-8696.
11. Grosschedl, R., and Baltimore, D. (1985). Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements. Cell 41, 885-897.
12. Hogan, B., Beddington, R., Constantini, F., and Lacy, E. (1994). Manipulating the Mouse Embryo: A Laboratory Manual, Second Edition (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press).
13. Kanzler, H., Kuppers, R., Hansmann, M.L., and Rajewsky, K. (1996). Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J. Exp. Med. 184, 1495-1505.
14. Katamine, S., Otsu, M., Tada, K., Tsuchiya, S., Sato, T., Ishida, N., Honjo, T., and Ono, Y. (1984). Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements. Nature 309, 369-372.
15. Kieff, E. (1996). Epstein-Barr virus and its replication. In Fundamental Virology, B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Lippincott-Raven), pp. 1109-1162.
16. Kitamura, D., Roes, J., Kuhn, R., and Rajewsky, K. (1991). A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene. Nature 350, 423-426.
17. Lam, K., Kuhn, R., and Rajewsky, K. (1997). In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 90, 1073-1083.
18. Lam, K.M., Syed, N., Whittle, H., and Crawford, D.H. (1991). Circulating Epstein-Barr virus-carrying B cells in acute malaria. Lancet 337, 876-878.
19. Lewin, N., Aman, P., Masucci, M.G., Klein, E., Klein, G., Oberg, B., Strander, H., Henle, W., and Henle, G. (1987). Characterization of EBV-carrying B-cell populations in healthy seropositive individuals with regard to density, release of transforming virus and spontaneous outgrowth. Int. J. Cancer 39, 472-476.
20. Longnecker, R., and Kieff, E. (1990). A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J. Virol. 64, 2319-2326.
21. Longnecker, R., and Miller, C.L. (1996). Regulation of Epstein-Barr virus latency by latent membrane protein 2. Trends Microbiol. 4, 38-42.
22. Longnecker, R., Druker, B., Roberts, T.M., and Kieff, E. (1991). An Epstein-Barr virus protein associated with cell growth transformation interacts with atyrosine kinase. J. Virol. 65, 3681-3692.
23. Longnecker, R., Miller, C.L., Miao, X.Q., Marchini, A., and Kieff, E. (1992). The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential. J. Virol. 66, 6461-6469.
24. Longnecker, R., Miller, C.L., Miao, X.Q., Tomkinson, B., and Kieff, E. (1993a). The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro. J. Virol. 67, 2006-2013.
25. Longnecker, R., Miller, C.L., Tomkinson, B., Miao, X.Q., and Kieff, E. (1993b). Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. J. Virol. 67, 5068-5074.
26. Marchini, A., Kieff, E., and Longnecker, R. (1993). Marker rescue of a transformation-negative Epstein-Barr virus recombinant from an infected Burkitt lymphoma cell line: a method useful for analysis of genes essential for transformation. J. Virol. 67, 606-609.
27. Miller, C.L., Longnecker, R., and Kieff, E. (1993). Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J. Virol. 67, 3087-3094.
28. Miller, C.L., Lee, J.H., Kieff, E., and Longnecker, R. (1994). An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl. Acad. Sci. USA 91, 772-776.
29. Miller, C.L., Burkhardt, A.L., Lee, J.H., Stealey, B., Longnecker, R., Bolen, J.B., and Kieff, E. (1995). Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity 2, 155-166.
30. Miyashita, E.M., Yang, B., Lam, K.M., Crawford, D.H., and Thorley-Lawson, D.A. (1995). A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80, 593-601.
31. Miyashita, E.M., Yang, B., Babcock, G.J., and Thorley-Lawson, D.A. (1997). Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J. Virol. 71, 4882-4891.
32. Mombaerts, P., Iacomini, J., Johnson, R.S., Herrup, K., Tonegawa, S., and Papaioannou, V.E. (1992). RAG-1-deficient mice have no mature B and T lymphocytes. Cell 68, 869-877.
33. Qu, L., and Rowe, D.T. (1992). Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol. 66, 3715-3724.
34. Rickinson, A.B., and Kieff, E. (1996). Epstein-Barr virus. In Fields Virology, B.N. Fields, D.M. Knipe, and P.M. Howley, eds. (Philadelphia, PA: Lippincott-Raven), pp. 2397-2446.
35. Rolink, A., and Melchers, F. (1991). Molecular and cellular origins of B lymphocyte diversity. Cell 66, 1081-1094.
36. Schlissel, M.S., and Baltimore, D. (1989). Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription. Cell 58, 1001-1007.
37. Schlissel, M.S., Corcoran, L.M., and Baltimore, D. (1991). Virus-transformed pre-B cells show ordered activation but not inactivation of immunoglobulin gene rearrangement and transcription. J. Exp. Med. 173, 711-720.
38. Shinkai, Y., Rathbun, G., Lam, K., Oltz, E.M., Stewart, V., Mendelsohn, M., Charon, J., Datta, M., Young, F., Stall, A.M., and Alt, F.W. (1992). RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855-867.
39. Spanopoulou, E., Roman, C.A.J., Corcoran, L.M., Schlissel, M.S., Silver, D.P., Nemazee, D., Nussenzweig, M.C., Shinton, S.A., Hardy, R.R., and Baltimore, D. (1994). Functional immunoglobulin transgenes guide ordered B-cell differentiation in Rag-1-deficient mice. Genes Dev. 8, 1030-1042.
40. Takahama, Y., Sugaya, K., Tsuda, S., Hasegawa, T., and Hashimoto, Y. (1995). Regulation of early T cell development by the engagement of TCR-β complex expressed on fetal thymocytes from TCR-β-transgenic scid mice. J. Immunol. 154, 5862-5869.
41. Tierney, R.J., Steven, N., Young, L.S., and Rickinson, A.B. (1994). Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68, 7374-7385.
42. Turner, M., Mee, P.J., Costello, P.S., Williams, O., Price, A.A., Duddy, L.P., Furlong, M.T., Geahlen, R.L., and Tybulewicz, V.L.J. (1995). Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature 378, 298-302.
43. Yao, Q.Y., Rickinson, A.B., and Epstein, M.A. (1985). A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int. J. Cancer 35, 35-42.
44. Yao, Q.Y., Ogan, P., Rowe, M., Wood, M., and Rickinson, A.B. (1989). Epstein-Barr virus-infected B cells persist in the circulation of acyclovir-treated virus carriers. Int. J. Cancer 43, 67-71.
45. Yao, Q.Y., Czarnecka, H., and Rickinson, A.B. (1991). Spontaneous outgrowth of Epstein-Barrvirus-positive B-cell lines from circulating human B cells of different buoyant densities. Int. J. Cancer 48, 253-257.